المؤلفون: Huang F; Lady Davis Institute.; Department of Experimental Medicine, and., Cai F; Lady Davis Institute.; Department of Experimental Medicine, and., Dahabieh MS; Lady Davis Institute.; Department of Experimental Medicine, and., Gunawardena K; Lady Davis Institute., Talebi A; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., El-Turk F; McGill University Health Centre, Montreal, Quebec, Canada.; Centre Hospitalier Universitaire Sainte Justine, Montreal, Quebec, Canada., Park JY; McGill University Health Centre, Montreal, Quebec, Canada., Li M; Lady Davis Institute.; Department of Experimental Medicine, and., Goncalves C; Lady Davis Institute., Gagnon N; Lady Davis Institute., Su J; Lady Davis Institute., LaPierre JH; Lady Davis Institute.; Department of Experimental Medicine, and., Gaub P; Centre de Recherche, CHU St. Justine, Montréal, Quebec, Canada., Joyal JS; Centre de Recherche, CHU St. Justine, Montréal, Quebec, Canada., Mitchell JJ; McGill University Health Centre, Montreal, Quebec, Canada., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Miller WH Jr; Lady Davis Institute.; Department of Experimental Medicine, and.; Department of Oncology, McGill University, Montreal, Quebec, Canada., Del Rincón SV; Lady Davis Institute.; Department of Experimental Medicine, and.; Department of Oncology, McGill University, Montreal, Quebec, Canada.

المصدر: The Journal of clinical investigation [J Clin Invest] 2023 Oct 16; Vol. 133 (20). Date of Electronic Publication: 2023 Oct 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Peroxisomes*/metabolism , Melanoma*/genetics, Humans ; Lipid Metabolism ; Ceramides/pharmacology ; Ceramides/metabolism

المؤلفون: Prabhu SA; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Moussa O; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Gonçalves C; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., LaPierre JH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Chou H; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Huang F; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada., Ferruzo PYM; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada., Guettler EM; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Soria-Bretones I; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kirby L; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gagnon N; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Su J; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Silvester J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Krisna SS; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada., Rose AAN; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada., Sheppard KE; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia., Cescon DW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada., Mallette FA; Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.; Department of Medicine, Université de Montréal, Montréal, Québec, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Del Rincon SV; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada., Miller WH; Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.; Division of Experimental Medicine, McGill University, Montréal, Québec, Canada.; McGill Centre for Translational Research in Cancer, McGill University, Montréal, Québec, Canada.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Feb 01; Vol. 22 (2), pp. 192-204.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Breast Neoplasms*/drug therapy , Protein Kinase Inhibitors*/pharmacology, Animals ; Mice ; Eukaryotic Initiation Factor-4E ; Piperazines/pharmacology ; Pyridines/pharmacology ; Antineoplastic Agents/pharmacology